?

Cancer Biology & Medicine

Official Journal of The Chinese Anti-Cancer Association

Cancer Biology & Medicine is a peer-reviewed open-access journal sponsored by the Chinese Anti-Cancer Association (CACA), which is the leading professional society of oncology in China. The journal adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee for Medical Journal Editors (ICMJE) and the guidelines of Committee on Publication Ethics (COPE). It is now indexed in PubMed/ PubMed Central, BIOSIS Previews, EMBASE, SCOPUS, EBSCO, DOAJ, and Chemical Abstracts.

Scope

Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: cancer genomics, cancer and stem cell biology, molecular and clinical immunology, cancer prevention and epidemiology, cancer biomarkers, radiation oncology, oncology clinical trials, mechanisms of drug sensitivity and resistance, targeted therapy and immunotherapy, multidisciplinary treatment and personalized medicine.

Content Categories

Original Article, Editorial, Perspective, Review, Minireview, Letter to the Editor, Practice Guideline, Meeting Report, and Case Report.

Subscription

Prices are in RMB and U.S. Dollars and include postage. All orders must be prepaid. 2016 prices are valid till December 31, 2016. Institutional Rates apply to libraries, college/university departments and other facilities and organizations involving multiple readerships. Personal Rates apply to individual customers. These subscriptions are limited to the personal use of the individual named on the subscription order.

? Institutional Subscription Rates

China: 480 RMB

Rest of the World: $240

? Personal Subscription Rates

China: 400 RMB

Rest of the World: $200

? Single Issue Rates

China: 110 RMB per issue plus

shipping

Rest of the World: $55 per issue

plus shipping

Editorial Correspondence

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer,

Huan-hu-xi Road, He-xi District, Tianjin 300060, China

Tel: 86-22-2352 2919

Fax: 86-22-2352 2919

E-mail: editor@cancerbiomed.org

Website: www.cancerbiomed.org

Copyright and Photocopying ? 2016 Cancer Biology & Medicine, the Chinese Anti-Cancer Association. All rights reserved. Cancer Biology & Medicine allows reasonable use of its published contributions by the authors. For third parties who intend to use the copyrighted materials of the journal, please send request to editor@ cancerbiomed.org for permission. Disclaimer

The Publisher, Society, and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, Society, and Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, Society, and Editors of the products advertised.

Published & Sponsored by the Chinese Anti-Cancer Association

Supervised by the China Association for Science and Technology

Printed by China (Tianjin) Railway Materials Printing Co.,Ltd.

Editor-in-Chief

Xi-Shan Hao, China

Executive Editor-in-Chief

Ning Zhang, China

Consultant

Run-Xian Bao, China

Webster Cavenee, USA

Bao-Cun Sun, China

Zhao-You Tang, China

Hong Xiao, China

Associate Editor-in-Chief

Xiu-Wu Bian, China

Kai Fu, USA

Mary Gospodarowicz, Canada

Feng-Ting Liu, UK

Raphael E. Pollock, USA

Er-Wei Song, China

Cheng-Chao Shou, China

Yun-Hua Yang, China

Qi-Min Zhan, China

Wei Zheng, USA

Peng-Bo Zhou, USA

Managing Editor

Hui-Qin Liu, China

Scientific Editor

Ying Li, China

Anje Scarfe, Australia

Production Editor

Wen Li, China

Editorial Board Member

John R. Adler Jr, USA

Riccardo Audisio, UK

Yi Ba, China

Vivian Barak, Israel

Robert C. Bast Jr, USA

Francesco Bertoni, Switzerland

Jean Yves Blay, France

Fatima Cardoso, Portugal

Franco Cavalli, Switzerland

Eduardo Cazap, Argentina

Wing C. Chan, USA

Wing-Cheong Chow, HK, China

Charles S. Cleeland, USA

Mario Dicato, Luxembourg

Julie Y. Djeu, USA

Jia Fan, China

Gregory N. Fuller, USA

Giuseppe Giaccone, USA

Ardeshir Gravamzadeh, Iran

Nagy A. Habib, UK

Marc-Eric Halatsch, Germany

Stanley R. Hamilton, USA

Ji-Hui Hao, China

Xiang-Huo He, China

David J. Hill, Australia

Yang-Long Hou, China

Kelly K. Hunt, USA

Wen-Qi Jiang, China

Daehee Kang, Korea

Niki Karachaliou, Spain

Michael Koutsilieris, Greece

Tezer Kutluk, Turkey

J?rgen Larsson, Sweden

Soo-Yong Lee, Korea

Irene M. Leigh, UK

Bing-Hui Li, China

Jin Li, China

Li Li, China

Qiang Li, China

Wen-Bin Li, China

Yan Li, China

Dong-Xin Lin, China

Pei-Fang Liu, China

Qiang Liu, China

Ya-Ping Liu, Australia

Zhe Liu, China

Zhi-Hua Liu, China

Bo Lu, USA

Min Lu, USA

Purvish M. Parikh, India

W. Jack Pledger, USA

Sibrand Poppema, Netherlands

Robert Z. Qi, HK, China

Lun-Xiu Qin, China

Xiu-Bao Ren, China

Chang Hun Rhee, Korea

Frank Romeo, Italy

Nathaniel Rothman, USA

Zong-Hong Shao, China

Chantragan Srisomsap, Thailand

Aru W. Sudoyo, Indonesia

Daniel Sullivan, USA

Kari J. Syrj?nen, Finland

Kazuo Tajima, Japan

Lim Soon Thye, Singapore

Gary M. K. TSE, HK, China

Julie M. Vose, USA

Hua-Qing Wang, China

Jie Wang, China

Lu-Hua Wang, USA

Qin-Hong Wang, USA

Xi Wang, USA

Ying Wang, China

Fu-Chan Wei, Taipei, China

Dennis Weisenburger, USA

Paul Workman, UK

Qiao Wu, China

Rui-Hua Xu, China

Fang Yan, USA

Xiang-Liang Yang, China

Hai-Fang Yin, China

Guo-Guang Ying, China

Herbert Yu, USA

Shi-Ying Yu, China

Shun-Jiang Yu, China

Yuan Yuan, China

Rong-Xin Zhang, China

Jian-Feng Zhou, China

Zong-Jian Zhu, USA

Christoph Zielinski, Austria

Heinz Zwierzina, Austria